NDRA
Price
$6.13
Change
-$0.87 (-12.43%)
Updated
Oct 17 closing price
Capitalization
4.61M
PSNL
Price
$9.13
Change
-$1.15 (-11.19%)
Updated
Oct 17 closing price
Capitalization
809.62M
17 days until earnings call
Interact to see
Advertisement

NDRA vs PSNL

Header iconNDRA vs PSNL Comparison
Open Charts NDRA vs PSNLBanner chart's image
ENDRA Life Sciences
Price$6.13
Change-$0.87 (-12.43%)
Volume$97.92K
Capitalization4.61M
Personalis
Price$9.13
Change-$1.15 (-11.19%)
Volume$2.06M
Capitalization809.62M
NDRA vs PSNL Comparison Chart in %
NDRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NDRA vs. PSNL commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDRA is a Hold and PSNL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (NDRA: $6.13 vs. PSNL: $9.13)
Brand notoriety: NDRA and PSNL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NDRA: 29% vs. PSNL: 207%
Market capitalization -- NDRA: $4.61M vs. PSNL: $809.62M
NDRA [@Medical Specialties] is valued at $4.61M. PSNL’s [@Medical Specialties] market capitalization is $809.62M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $11.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NDRA’s FA Score shows that 1 FA rating(s) are green whilePSNL’s FA Score has 0 green FA rating(s).

  • NDRA’s FA Score: 1 green, 4 red.
  • PSNL’s FA Score: 0 green, 5 red.
According to our system of comparison, both NDRA and PSNL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NDRA’s TA Score shows that 5 TA indicator(s) are bullish while PSNL’s TA Score has 5 bullish TA indicator(s).

  • NDRA’s TA Score: 5 bullish, 3 bearish.
  • PSNL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NDRA is a better buy in the short-term than PSNL.

Price Growth

NDRA (@Medical Specialties) experienced а -5.40% price change this week, while PSNL (@Medical Specialties) price change was +12.44% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.25%. For the same industry, the average monthly price growth was +3.05%, and the average quarterly price growth was +51.76%.

Reported Earning Dates

PSNL is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical Specialties (+0.25% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PSNL($810M) has a higher market cap than NDRA($4.61M). PSNL YTD gains are higher at: 57.958 vs. NDRA (-2.077). NDRA has higher annual earnings (EBITDA): -8.4M vs. PSNL (-80.8M). PSNL has more cash in the bank: 173M vs. NDRA (1.81M). NDRA has less debt than PSNL: NDRA (557K) vs PSNL (42.4M). PSNL has higher revenues than NDRA: PSNL (80.3M) vs NDRA (0).
NDRAPSNLNDRA / PSNL
Capitalization4.61M810M1%
EBITDA-8.4M-80.8M10%
Gain YTD-2.07757.958-4%
P/E Ratio0.01N/A-
Revenue080.3M-
Total Cash1.81M173M1%
Total Debt557K42.4M1%
FUNDAMENTALS RATINGS
NDRA vs PSNL: Fundamental Ratings
NDRA
PSNL
OUTLOOK RATING
1..100
5092
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
4335
P/E GROWTH RATING
1..100
15100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PSNL's Valuation (49) in the null industry is somewhat better than the same rating for NDRA (91) in the Biotechnology industry. This means that PSNL’s stock grew somewhat faster than NDRA’s over the last 12 months.

PSNL's Profit vs Risk Rating (100) in the null industry is in the same range as NDRA (100) in the Biotechnology industry. This means that PSNL’s stock grew similarly to NDRA’s over the last 12 months.

PSNL's SMR Rating (98) in the null industry is in the same range as NDRA (99) in the Biotechnology industry. This means that PSNL’s stock grew similarly to NDRA’s over the last 12 months.

PSNL's Price Growth Rating (35) in the null industry is in the same range as NDRA (43) in the Biotechnology industry. This means that PSNL’s stock grew similarly to NDRA’s over the last 12 months.

NDRA's P/E Growth Rating (15) in the Biotechnology industry is significantly better than the same rating for PSNL (100) in the null industry. This means that NDRA’s stock grew significantly faster than PSNL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NDRAPSNL
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
NDRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JRSNX12.940.08
+0.62%
JH Adaptive Risk Mgd U.S. Eq N
MITJX36.760.22
+0.60%
MFS Massachusetts Investors Tr R6
VLIFX34.870.09
+0.26%
Value Line Mid Cap Focused
AAEMX12.93N/A
N/A
Alger Emerging Markets A
RTIYX12.47-0.02
-0.16%
Russell Inv Multifactor Intl Eq Y

NDRA and

Correlation & Price change

A.I.dvisor tells us that NDRA and GMED have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDRA and GMED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDRA
1D Price
Change %
NDRA100%
-12.43%
GMED - NDRA
29%
Poorly correlated
+1.72%
ICUI - NDRA
24%
Poorly correlated
+1.69%
CNMD - NDRA
23%
Poorly correlated
+0.51%
PSNL - NDRA
22%
Poorly correlated
-11.19%
EXAS - NDRA
22%
Poorly correlated
-0.10%
More

PSNL and

Correlation & Price change

A.I.dvisor indicates that over the last year, PSNL has been loosely correlated with TWST. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PSNL jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSNL
1D Price
Change %
PSNL100%
-11.19%
TWST - PSNL
43%
Loosely correlated
-8.42%
BLFS - PSNL
41%
Loosely correlated
-1.48%
CRL - PSNL
41%
Loosely correlated
+2.04%
CERS - PSNL
41%
Loosely correlated
-3.16%
CLPT - PSNL
40%
Loosely correlated
+0.38%
More